Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Ovarian Neoplasms

  Free Subscription


18.09.2017

4 Am J Surg Pathol
1 Br J Cancer
1 Cancer
3 Gynecol Oncol
3 Hum Pathol
1 Int J Oncol
2 Oncogene
2 Oncol Rep


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Surg Pathol

  1. DE KOCK L, Terzic T, McCluggage WG, Stewart CJR, et al
    DICER1 Mutations Are Consistently Present in Moderately and Poorly Differentiated Sertoli-Leydig Cell Tumors.
    Am J Surg Pathol. 2017;41:1178-1187.
    PubMed     Text format     Abstract available

  2. GRU AA, Williams ES, Cao D
    Mixed Gonadal Germ Cell Tumor Composed of a Spermatocytic Tumor-Like Component and Germinoma Arising in Gonadoblastoma in a Phenotypic Woman With a 46, XX Peripheral Karyotype: Report of the First Case.
    Am J Surg Pathol. 2017;41:1290-1297.
    PubMed     Text format     Abstract available

  3. MESBAH ARDAKANI N, Giardina T, Amanuel B, Stewart CJ, et al
    Molecular Profiling Reveals a Clonal Relationship Between Ovarian Mucinous Tumors and Corresponding Mural Carcinomatous Nodules.
    Am J Surg Pathol. 2017 May 11. doi: 10.1097/PAS.0000000000000875.
    PubMed     Text format     Abstract available

  4. KIHARA A, Yoshida H, Watanabe R, Takahashi K, et al
    Clinicopathologic Association and Prognostic Value of Microcystic, Elongated, and Fragmented (MELF) Pattern in Endometrial Endometrioid Carcinoma.
    Am J Surg Pathol. 2017 Apr 17. doi: 10.1097/PAS.0000000000000856.
    PubMed     Text format     Abstract available


    Br J Cancer

  5. WANG X, Zhu Q, Lin Y, Wu L, et al
    Crosstalk between TEMs and endothelial cells modulates angiogenesis and metastasis via IGF1-IGF1R signalling in epithelial ovarian cancer.
    Br J Cancer. 2017 Sep 12. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available


    Cancer

  6. MOORE KN, Borghaei H, O'Malley DM, Jeong W, et al
    Phase 1 dose-escalation study of mirvetuximab soravtansine (IMGN853), a folate receptor alpha-targeting antibody-drug conjugate, in patients with solid tumors.
    Cancer. 2017;123:3080-3087.
    PubMed     Text format     Abstract available


    Gynecol Oncol

  7. COWAN RA, Tseng J, Murthy V, Srivastava R, et al
    Feasibility, safety and clinical outcomes of cardiophrenic lymph node resection in advanced ovarian cancer.
    Gynecol Oncol. 2017 Sep 6. pii: S0090-8258(17)31270.
    PubMed     Text format     Abstract available

  8. LILYQUIST J, LaDuca H, Polley E, Davis BT, et al
    Frequency of mutations in a large series of clinically ascertained ovarian cancer cases tested on multi-gene panels compared to reference controls.
    Gynecol Oncol. 2017 Sep 7. pii: S0090-8258(17)31268.
    PubMed     Text format     Abstract available

  9. PISU M, Kenzik KM, Rim SH, Funkhouser EM, et al
    Values and worries of ovarian cancer patients.
    Gynecol Oncol. 2017 Sep 6. pii: S0090-8258(17)31267.
    PubMed     Text format     Abstract available


    Hum Pathol

  10. AMAN M, Ohishi Y, Imamura H, Shinozaki T, et al
    Expression of protease-activated receptor-2 (PAR-2) is related to advanced clinical stage and adverse prognosis in ovarian clear cell carcinoma.
    Hum Pathol. 2017 Apr 21. pii: S0046-8177(17)30123.
    PubMed     Text format     Abstract available

  11. KIM WY, Shim SH, Jung HY, Dong M, et al
    The gene copy number of c-MET has a significant impact on progression-free survival in Korean patients with ovarian carcinoma.
    Hum Pathol. 2017 Apr 17. pii: S0046-8177(17)30108.
    PubMed     Text format     Abstract available

  12. RAWISH KR, Desouki MM, Fadare O
    Atypical Mucinous Glandular Proliferations in Endometrial Samplings: Follow-Up and Other Clinicopathologic Findings In 41 cases.
    Hum Pathol. 2017 Feb 20. pii: S0046-8177(17)30048.
    PubMed     Text format     Abstract available


    Int J Oncol

  13. GUO J, Cai J, Zhang Y, Zhu Y, et al
    Establishment of two ovarian cancer orthotopic xenograft mouse models for in vivo imaging: A comparative study.
    Int J Oncol. 2017;51:1199-1208.
    PubMed     Text format     Abstract available


    Oncogene

  14. HARJES U, Bridges E, Gharpure KM, Roxanis I, et al
    Antiangiogenic and tumour inhibitory effects of downregulating tumour endothelial FABP4.
    Oncogene. 2017;36:912-921.
    PubMed     Text format     Abstract available

  15. HWANG MH, Cho KH, Jeong KJ, Park YY, et al
    RCP induces Slug expression and cancer cell invasion by stabilizing beta1 integrin.
    Oncogene. 2017;36:1102-1111.
    PubMed     Text format     Abstract available


    Oncol Rep

  16. GAO J, Zhu H, Wan H, Zou X, et al
    Harmine suppresses the proliferation and migration of human ovarian cancer cells through inhibiting ERK/CREB pathway.
    Oncol Rep. 2017 Sep 13. doi: 10.3892/or.2017.5952.
    PubMed     Text format     Abstract available

  17. PARK GB, Kim D
    TLR5/7-mediated PI3K activation triggers epithelial-mesenchymal transition of ovarian cancer cells through WAVE3-dependent mesothelin or OCT4/SOX2 expression.
    Oncol Rep. 2017 Sep 6. doi: 10.3892/or.2017.5941.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ovarian Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: